Literature DB >> 32719036

React, reset and restore: Adaptation of a large inflammatory bowel disease service during COVID-19 pandemic.

Haidee A Gonzalez1, Sally Myers1, Emma Whitehead1, Alisson Pattinson1, Katie Stamp1, Jack Turnbull1, Rebecca Fory1, Bethia Featherstone1, Amy Wilkinson1, Jessica Lisle1, Greg Haire1, Eileen Henderson1, Shaji Sebastia2.   

Abstract

INTRODUCTION: Healthcare organisations have had to make adaptations to reduce the impact of the Coronavirus 2019 (COVID-19) pandemic. This has necessitated urgent reconfiguration within inflammatory bowel disease (IBD) services to ensure safety of patients and staff and seamless continuity of care provision. AIM: To describe the adaptations made by a large inflammatory bowel disease service, caring for over 3,500 IBD patients, in response to the COVID-19 pandemic.
METHODS: A diary record of responses to the pandemic were logged, and meeting minutes were reviewed. Data were recorded from IBD advice lines, multidisciplinary team (MDT) meeting minutes, infusion unit attendances, and electronic referral systems for the 8-week period from 9 March 2020 until 2 May 2020. Descriptive analysis was performed.
RESULTS: The IBD service at Hull University Teaching Hospitals NHS Trust (IBD Hull) instituted rapid structural and functional changes to the service. Outpatient services were suspended and substituted by virtual consultations, and inpatient services were reduced and moved to ambulatory care where possible. The delivery of biologic and immunomodulatory therapies was significantly modified to ensure patient and staff safety. There was a substantial increase in IBD advice line calls.
CONCLUSION: The rapidly evolving COVID-19 pandemic required a prompt response, regular reassessment and planning, and continues to do so. We share our experience in of the successful adaptations made to our IBD service. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  COVID-19; IBD; adaptations

Mesh:

Year:  2020        PMID: 32719036      PMCID: PMC7539744          DOI: 10.7861/clinmed.2020-0369

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  15 in total

1.  A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).

Authors:  Raymond K Cross; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Joseph F Collins; Jonathan Katz; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Dawn Beaulieu; Sara N Horst; Katharine Russman; Mahrukh Riaz; Guruprasad Jambaulikar; Barathi Sivasailam; Charlene C Quinn
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

2.  Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.

Authors:  Cristina Bezzio; Simone Saibeni; Angela Variola; Mariangela Allocca; Alessandro Massari; Viviana Gerardi; Valentina Casini; Chiara Ricci; Fabiana Zingone; Arnaldo Amato; Flavio Caprioli; Marco Vincenzo Lenti; Chiara Viganò; Marta Ascolani; Fabrizio Bossa; Fabiana Castiglione; Claudio Cortelezzi; Laurino Grossi; Monica Milla; Daniela Morganti; Luca Pastorelli; Davide Giuseppe Ribaldone; Alessandro Sartini; Alessandra Soriano; Gianpiero Manes; Silvio Danese; Massimo Claudio Fantini; Alessandro Armuzzi; Marco Daperno; Gionata Fiorino
Journal:  Gut       Date:  2020-04-30       Impact factor: 23.059

3.  Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD.

Authors:  S Sebastian; H A Gonzalez; L Peyrin-Biroulet
Journal:  J Crohns Colitis       Date:  2020-06-10       Impact factor: 9.071

4.  Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.

Authors:  David T Rubin; Maria T Abreu; Victoria Rai; Corey A Siegel
Journal:  Gastroenterology       Date:  2020-04-06       Impact factor: 22.682

5.  British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Authors:  Nicholas A Kennedy; Gareth-Rhys Jones; Christopher A Lamb; Richard Appleby; Ian Arnott; R Mark Beattie; Stuart Bloom; Alenka J Brooks; Rachel Cooney; Robin J Dart; Cathryn Edwards; Aileen Fraser; Daniel R Gaya; Subrata Ghosh; Kay Greveson; Richard Hansen; Ailsa Hart; A Barney Hawthorne; Bu'Hussain Hayee; Jimmy K Limdi; Charles D Murray; Gareth C Parkes; Miles Parkes; Kamal Patel; Richard C Pollok; Nick Powell; Chris S Probert; Tim Raine; Shaji Sebastian; Christian Selinger; Philip J Smith; Catherine Stansfield; Lisa Younge; James O Lindsay; Peter M Irving; Charlie W Lees
Journal:  Gut       Date:  2020-04-17       Impact factor: 23.059

Review 6.  Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.

Authors:  Marietta Iacucci; Rosanna Cannatelli; Nunzia Labarile; Ren Mao; Remo Panaccione; Silvio Danese; Gursimran S Kochhar; Subrata Ghosh; Bo Shen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-04-16

7.  Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.

Authors:  Mariangela Allocca; Gionata Fiorino; Federica Furfaro; Daniela Gilardi; Simona Radice; Ferdinando D'Amico; Alessandra Zilli; Silvio Danese
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 11.382

8.  2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.

Authors:  Carlos Taxonera; Iñigo Sagastagoitia; Cristina Alba; Norberto Mañas; David Olivares; Enrique Rey
Journal:  Aliment Pharmacol Ther       Date:  2020-06-07       Impact factor: 9.524

9.  Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).

Authors:  Iago Rodríguez-Lago; Patricia Ramírez de la Piscina; Ainara Elorza; Olga Merino; Jone Ortiz de Zárate; José Luis Cabriada
Journal:  Gastroenterology       Date:  2020-04-21       Impact factor: 22.682

10.  Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?

Authors:  Giovanni Monteleone; Sandro Ardizzone
Journal:  J Crohns Colitis       Date:  2020-09-16       Impact factor: 9.071

View more
  1 in total

Review 1.  Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Mariusz A Bromke; Katarzyna Neubauer; Radosław Kempiński; Małgorzata Krzystek-Korpacka
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.